GLOBAL BLOOD THERAPEUTICS IN (GBT)
US37890U1088 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -322.46M | -303.09M | -247.55M | -266.77M | -174.19M | |||
| Depreciation Amortization | 6.05M | 5.91M | 8.32M | 8.61M | 4.61M | |||
| Change In Working Capital | -14.85M | -42.44M | -47.27M | 27.08M | 4.75M | |||
| Interest Paid | 21.66M | 13.94M | 6.28M | N/A | N/A | |||
| Other non cash items | 81.86M | 82.81M | 74.64M | 36.66M | 29.46M | |||
| OPERATING CASH FLOW | -249.40M | -256.81M | -211.86M | -194.42M | -135.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.95M | -3.23M | -8.75M | -3.46M | -4.82M | |||
| Other Investing Activity | -388.85M | 15.34M | 326.07M | -73.40M | -179.33M | |||
| INVESTING CASH FLOW | -390.80M | 12.11M | 317.31M | -76.86M | -184.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 96.47M | 74.80M | 72.48M | N/A | |||
| Stock Issued/Repurchased | 388.19M | 340.98M | 17.61M | 233.30M | 404.16M | |||
| Other Financing Activity | -2.20M | -3.11M | -5.29M | -7.62M | -6.25M | |||
| FINANCING CASH FLOW | 482.46M | 434.33M | 87.12M | 298.16M | 397.91M | |||
| Exchange Rate Effect | -386.00K | 319.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -158.12M | 189.95M | 192.57M | 26.88M | 78.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -249.40M | -256.81M | -211.86M | -194.42M | -135.38M | |||
| Capital Expenditure | -1.95M | -3.23M | -8.75M | -3.46M | -4.82M | |||
| FREE CASH FLOW | -251.35M | -260.05M | -220.61M | -197.88M | -140.20M | |||
All data in USD